NuTRIflex Lipid peri 1.872 g/1000 mL+ 2.504 g/1000 mL+ 2.272 g/1000 mL+ 1.568 g/1000 mL+ 2.808 g/1000 mL+ 1.456 g/1000 mL+ 0.456 บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

nutriflex lipid peri 1.872 g/1000 ml+ 2.504 g/1000 ml+ 2.272 g/1000 ml+ 1.568 g/1000 ml+ 2.808 g/1000 ml+ 1.456 g/1000 ml+ 0.456

b.braun adria bh d.o.o. - aminokiseline, glukoza, lipidi mjestu - emulzija za infuziju - 1.872 g/1000 ml+ 2.504 g/1000 ml+ 2.272 g/1000 ml+ 1.568 g/1000 ml+ 2.808 g/1000 ml+ 1.456 g/1000 ml+ 0.456 g/1000 ml+ 2.08 g/10 - 1000 ml emulzija za infuziju sadrži: 1,872 g izoleucin, 2,504 g leucin, 2,272 g lizin (u obliku lizinhidrohlorida), 1,568 g metionin, 2,808 g fenilalanin, 1,456 g treonin, 0,456 g triptofan, 2,080 g valin, 2,160 g arginin, 1,352 g histidinhidrohlorid, monohidrat, 3,880 g alanin, 1,320 g glicin, 1,200 g asparaginska kiselina, 2,800 g glutaminska kiselina, 2,720 g prolin, 2,400 g serin, 0,865 g natrijumhlorid, 0,435 g natrijumacetat, trihidrat, 2,354 g kalijumacetat, 0,515 g magnezijumacetat, tetrahidrat, 0,353 g kalcijumhlorid, dihidrat, 0,640 g natrijumhidroksid, 64,000 g glukoza (u obliku glukoza, monohidrata), 0,936 g natrijumdihidrogenfosfat, dihidrat, 5,280 g cinkacetat, dihidrat, 20,000 g trigliceridi, srednjelančani, 20,000 g sojino ulje, pročišćeno

MEGLIMID 4 mg/1 tableta tableta บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

meglimid 4 mg/1 tableta tableta

krka farma d.o.o. sarajevo - glimepirid - tableta - 4 mg/1 tableta - 1 tableta sadrži: 4 mg glimepirida

ASTMASAN 4 mg/1 kesica granule บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

astmasan 4 mg/1 kesica granule

novartis ba d.o.o. - montelukast - granule - 4 mg/1 kesica - 1 kesica sa granulama sadrži: 4 mg montelukasta

Deferasirox Accord สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

deferasirox accord

accord healthcare s.l.u. - deferasirox - iron overload; beta-thalassemia - sve ostale lekovita sredstva, glačalo chelating posrednika - Деферазирокс pristanka indiciran za liječenje kroničnog preko-zasićenih željezom zbog čestih переливаний krvi (≥7 ml/kg/mjesec эритроцитарной mase) u bolesnika s beta-талассемией gradonačelnik u dobi od 6 godina i starije. Деферазирокс accord je također indiciran za liječenje kronične preko-zasićenih željezom zbog трансфузий krvi, kada je terapija дефероксамином kontraindiciran ili неадекватна od sljedećih skupina bolesnika:kod pedijatrijska bolesnika s beta-талассемией s preopterećenje željezom zbog čestih переливаний krvi (≥7 ml/kg/mjesec эритроцитарной mase) u dobi od 2 do 5 godina,kod odraslih i pedijatrijska bolesnika s beta-талассемией s preopterećenje željezom zbog rijetke krvi (.

RABIKAL โครเอเชีย - โครเอเชีย - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

rabikal

genera d.d., svetonedeljska cesta 2, kalinovica, 10436 rakov potok, hrvatska - inaktivirani virus bjesnoće, soj flury lep - suspenzija za injekciju - pasa, mačaka

SALOFALK 1.5 g/1 kesica gastrorezistentne granule บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

salofalk 1.5 g/1 kesica gastrorezistentne granule

ewopharma d.o.o. sarajevo - месалазин - gastrorezistentne granule - 1.5 g/1 kesica - 1 kesica sa gastrorezistentnim granulama sadrži: 1,5 g mesalazina

SALOFALK 3 g/1 kesica gastrorezistentne granule บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

salofalk 3 g/1 kesica gastrorezistentne granule

ewopharma d.o.o. sarajevo - месалазин - gastrorezistentne granule - 3 g/1 kesica - 1 kesica sa gastrorezistentnim granulama sadrži: 3 g mesalazina

LETRASAN 2.5 mg/1 tableta filmom obložena tableta บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

letrasan 2.5 mg/1 tableta filmom obložena tableta

unifarm d.o.o. lukavac - letrozol - filmom obložena tableta - 2.5 mg/1 tableta - jedna filmom obložena tableta sadrži: 2,5 mg letrozola

Abiraterone Accord สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Mylan สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateron acetat - prostatske neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.